Document Detail


Ameliorating effects of cloperastine on dysfunction of the urinary bladder caused by cerebral infarction in conscious rats.
MedLine Citation:
PMID:  19935896     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated the effects of the centrally acting antitussives dextromethorphan and cloperastine on urinary bladder dysfunction 24 h after cerebral infarction in rats using the cystometry technique. First, cystometrography was performed in conscious male Sprague-Dawley rats. Cerebral infarction was then induced by occlusion of the left middle cerebral artery. Twenty-four hours after cerebral infarction, the effect of each drug on micturition disorder was estimated for 5 parameters: bladder capacity, maximum voiding pressure, micturition latency, flow rate, and urethral resistance. Cerebral infarction markedly reduced bladder capacity, micturition latency, and flow rate and increased urethral resistance. After cerebral infarction, intravenous dosing of saline had no effect on these parameters. Dextromethorphan (20 mg/kg) and cloperastine (2.5 and 5.0 mg/kg) at antitussive effective doses significantly increased bladder capacity and micturition latency. Unlike dextromethorphan, cloperastine ameliorated decreases in flow rate and increases in urethral resistance caused by cerebral infarction. These results suggest that cloperastine may have therapeutic value for the treatment of disorders of the micturition reflex associated with cerebral infarction, and that the drug may become a base compound from which to develop more active drugs for such disorders.
Authors:
Gen Yamamoto; Fumio Soeda; Tetsuya Shirasaki; Kazuo Takahama
Related Documents :
16833026 - Lacunar infarct.
21863696 - Unilateral ptosis associated with paramedian thalamiic infarction.
2614926 - Risk factors for the complication of cerebral infarction in japanese patients with acut...
11807396 - Dynamic changes in cortical nadh fluorescence and direct current potential in rat focal...
21044916 - Value and limitations of electromechanical endocardial mapping in the assessment of glo...
11703986 - Clinical and angiographic correlates of dobutamine-induced wall motion patterns after m...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Canadian journal of physiology and pharmacology     Volume:  87     ISSN:  1205-7541     ISO Abbreviation:  Can. J. Physiol. Pharmacol.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-25     Completed Date:  2010-02-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372712     Medline TA:  Can J Physiol Pharmacol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  893-9     Citation Subset:  IM    
Affiliation:
Department of Environmental and Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antitussive Agents / therapeutic use*
Ataxia / drug therapy,  etiology
Dextromethorphan / therapeutic use*
Diagnostic Techniques, Urological
Infarction, Middle Cerebral Artery / complications*,  physiopathology
Male
Piperidines / therapeutic use*
Rats
Rats, Sprague-Dawley
Urinary Bladder / drug effects
Urinary Bladder, Overactive / drug therapy*,  etiology
Urination / drug effects
Chemical
Reg. No./Substance:
0/Antitussive Agents; 0/Piperidines; 125-71-3/Dextromethorphan; 3703-76-2/cloperastine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recovery of antimicrobial-resistant Escherichia coli after storage of bovine feces in Cary-Blair med...
Next Document:  Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti...